Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5361_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
23 Мб
Скачать
82
A. Chakraborty et al.
label- free mechanics used, the ease of miniaturization, low cost and easy processing of electrical biosensor make them the point-of-care in disease diagnostics [9].
There are different transducer mechanisms used in biosensors like electrochemi­cal, optical, thermal and calorimetric [10]. While chemiluminescent, absorbance, and uorescence are basic mechanisms behind optical transducer signal output, the mechanism of the electrochemical transducer biosensor is generally conductometric [11, 12]. Based on the nature of the transducer used, the signal is received from the bioreceptor and further conveyed to the processor. In between this, the signal is amplied while the output amplitude is proportional to the analyte’s concentration [13]. On binding of the analyte to the bioreceptor, a change in physiochemical sig­nal is captured and converted to electrical signal by transducer. Analysis of the changes in different parameters of the signal like conductance, intensity, and poten­tial reveals the presence or absence of bioagent [7]. Apart from biotransducer, there are other vital components of a biosensor, microprocessor, monitor and most impor­tant, the bioreceptor, which is specic for biorecognition, to detect the analyte [14, 15].
In spite of all these advantages, there are few hurdles that prevent the wide-scale use of afnity biosensor in disease diagnostics. First is multiplexing, i.e., the ability to detect a wide range of analytes in a single sample. The second obstacle is the high detection limit. These problems can be overcome by the implementation of nanoscale biosensor as the potential candidate, with increased sensitivity and lower detection limit [16]. The use of nanotechnology allows manipulation at the atomic level where the dimension remains in the range of 1–100 nm scale [17]. Their extremely small size improves performance in electrochemical and enzymatic bio­sensors by increasing the electron transfer rates as well as by shortening enzyme-to­electrode distances [18].
Nanosensors have the special advantage of displaying signicant levels of detec­tion sensitivity, pertaining to their unique physical, chemical, mechanical magnetic and optical features [19]. Several nanomaterials like nanoparticles, nanotubes, nanowires, nanorods and nanostructured surfaces have been widely explored in the eld of biological signalling due to their excellent hardiness, portability as well as electrical and mechanical properties [20]. Some of the fundamental properties of nanomaterials like tunnelling and quantum effects and high surface-to-volume ratio, make these nanobiosensors inimitable in today’s eld of disease diagnosis [21].
Therefore, the high selectivity and sensitivity of biosensor ease out early diagno­sis and management of diseases through facilitating timely therapy decisions and implementation of nanobiosensor can improve the assessment of the prognosis of a disease and its progression important for the effective treatment of many diseases [22]. This book chapter will help to develop an overall knowledge about recent development in the eld of nanobiosensor with special reference to their application in the treatment of human inammatory diseases (Fig.3.1).
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
Fig. 3.1 Recently developed nano-biosensors and their applications
83
3.2 Technological Outlines inDeveloping Nanobiosensors
Nanobiosensors are the result of modern advancement in the elds of nanotechnol­ogy and electronics fabrication. This new generation of nanoscale biosensors has taken huge strides in making nanobiotechnology extremely useful for disease diag­nosis. Nanobiosensors are very similar in their mode of action to other biosensors that measure a biochemical event employing optical, electronic or magnetic detec­tion methods except for they use extremely compact probes for transducing the signal [2325].
Modern health monitoring and disease detection procedures rely immensely on rapid, extremely precise and real-time detection of biological events which in turn aids in rapid decision-making and life-saving manipulations. Nanoscale biosensors that incorporate nanotechnology with biological detection molecules have helped scientists achieve this feat very efciently [7, 26].
3.2.1 Importance ofNanotechnology inBiosensing
Nanobiosensors are essentially biosensors which have nanomaterials incorporated at their core. A nanomaterial comprises of nanoparticles (NPs) that are less than 100nm at least in one dimension [7]. When scaled down to a nanoscale, most mate­rials have most of their constituent atoms located at or near their surface and exhibit novel properties that cannot be extrapolated from their bulk behaviour [24]. Nanobiosensors show signicant advantages in terms of sensitivity and specicity,
84
in contrast to old-school biosensors. From the detection of biomolecules like nucleic acids, proteins, immunologic molecules to environmental pollutants or any other small and sparse molecules, the detection prowess of nanobiosensors has estab­lished their potential in therapeutic, food and drug quality or environmental assess­ment [23, 24].
Nanoscale biosensors can overcome many obstacles that impede the widespread use of afnity biosensors without many of the major drawbacks. For example, in case of designing afnity-based biosensors, two major targets are to achieve lower detection limit and to detect multiple analysts for a single sample [7]. Lower detec­tion limit for example can be achieved by altering the thermodynamics of the afn­ity reaction [7]. Using nanomaterials in developing biosensors provides a surface area-to-volume ratio far greater than using bulk materials. This, in turn, aids the nanobiosensors to be extremely sensitive to even trace amounts of target mole­cules [27].
A. Chakraborty et al.
3.2.2 Classication ofNanomaterials
Nanomaterials can be broadly classied into four types according to size and dimen­sions namely: zero dimensional (0D), one dimensional (1D) and two dimensional (2D) [28, 29].
In 0D nanomaterials, all three dimensions of materials are in nanoscale, i.e. <100 nm. Nanoparticles of metals like silver, gold, palladium, etc. and quantum dots are amongst the most used 0D nanomaterials.
1D nanomaterials usually have two of the three dimensions in the nanoscale, while the other in the macroscale. They are mostly lamentous in shape with their diameter in nanoscale. Metal nanoparticles or quantum dots are often used to develop these structures that include nanobers, nanowires, nanotubes, etc.
In 2D class of nanomaterials, two dimensions are in macroscale and one dimen­sion is in nanoscale, i.e. they have very low thickness of <100nm while extended in the other two-dimensional plane. Example includes nanolms, multi-layered nano­lms, nanosheets, etc.
Except for these three groups of nanomaterials, most other materials used in biosensor development are three-dimensional (3D), which have all dimensions in the macroscale rather than in the nanoscale. However, these bulk materials may be composed of individual building nanoblocks belonging to the nanoscale.
3.2.3 Nanomaterials Used inDesigning Biosensors
A biosensor is typically made up of three components:
A bioreceptor that serves as a template for the analyte binding.
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
85
A transducer that, as its name suggests, transforms the binding biochemical energy
of analyte with its bioreceptor to electrical energy, and A detector system that typically receives the electrical signal from transducers and
amplies and documents the signal to a perceivable form.
The basic blueprint for nanobiosensors is exactly the same. In addition to these features, the transducer portion of a nanobiosensor must have immobilization prop­erty that immobilizes bioreceptors on its surface.
Nanoparticles Metal nanoparticles show great potential in terms of stability and
sensitivity at low concentration of analytes, when used in electrochemical nanobio­sensors. Noble metal nanoparticles are widely used in biosensors for their exibility of sizes and compositions that suits different applications. Noble metal nanoparti­cles have been found to possess exemplary therapeutic efciency in connection with antimicrobial properties, low doses of treatment and negligible toxicity [30]. Among the top used nanoparticles, gold nanoparticles when used to immobilize the biocom­ponents have shown excellent biocompatibility and electroanalytical potential. Enzyme immobilization using nanoparticles provides greater stability in the biosen­sors for longer along with improving its analytical sensitivity. According to Mukherjee etal. (2013), naturally existing enzymes like polyphenol oxidases (PPO) are found to hold efcacy in wide temperature and pH ranges especially when immobilized on some matrix [31]. Silver nanoparticles (AgNPs) are a second group of commonly used nanoparticles in biosensing and drug-delivery systems. An attempt by Dey etal. (2016) utilized AgNPs as efcient in-cell delivery agents for antibiotic and antilarial drugs by stabilizing them via a non-toxic supramolecular hydrogel network, following previous reports of potency of DNA and SHGel­capped AgNPs against various pathogens and parasites. A very interesting example of green synthesis approaches like harnessing sunlight to generate AgNPs has also been set forth by the same group [32].
Lanthanide luminescent nanoparticles, having prolonged light-emitting property, make them excellent probes for nanoscale time-resolved uorometery biosensors.
Iron oxide nanoparticles due to biocompatibility and paramagnetic properties have excellent immobilization property for the biocomponents [7, 26].
Nanowires Being one-dimensional system, current ow in nanowires/nanobers
is extremely sensitive to minor alterations generated by interaction with biocompo­nents. Its 1D nature means current ows almost at the surface. Due to these proper­ties and also its inherent nature to bind to biological analytes to their surface helps in generating direct, label-free electrical nanobiosensor. These biosensors based on eld effect transistor principles thus are very effective in detecting a host of analytes ranging from DNA sequences to cancer biomarkers to even whole viruses [7, 26].
Carbon nanotubes (CNT) Carbon nanotubes are other 1D nanomaterials that due to their unique electrical and mechanical properties have found their way in several nanobiosensing applications. They can be single-walled or multi-walled CNTs, and
86
A. Chakraborty et al.
have high stability, excellent thermal conductivity and high surface-to-volume ratio. Due to these unique features, even minor disturbances on its surface (e.g. binding of analytes) alter its electronic conductance and generate a strong signal. Thus, CNT­based nanobiosensors are widely used in healthcare as well as environmental detec­tions [7, 29].
Graphene Graphene, formed by sp2 electron-hybridized carbon atom, is an atomi-
cally thin layer with excellent electron transport properties, high thermal conductiv­ity, adjustable optical property, extremely high tensile strength and superior specic surface area. Its structure with a porous framework provides excellent opportunity for surface immobilization of bioreceptors and provides stable surface for bioana­lyte interactions. Thus, graphene and graphene derivatives have been extensively used in developing optical, uorescence, impedance and electrochemical biosensors that can detect numerous analytes such as biological macromolecules like DNA, cytochromes, glucose, cholesterol, vitamins, catechol and inorganic molecules including heavy metals and gases [25, 33].
Quantum dots Quantum dots are modern-day zero-dimensional nanoparticles having 1–10nm size, which have gained extensive utility in contemporary nanobio­sensor designs. They have unique optoelectrical properties including wide excita­tion spectral range, narrow, sharp and controllable emission spectral band, low photo-bleaching and superior photochemical stability. The photoemission of quan­tum dots is related to its size and surface structure and hence, when molecules and ions bind to their surface, altering their size and surface properties, the emission intensity or colour changes. Instances have been found of associating different bio­logical heteroatoms with graphene quantum dots to enhance their photolumines­cence and electrochemical performance, to eventually conjugate these with streptomycin, a common antibiotic and successfully develop drug-conjugated bio­compatible quantum dots [34].
Multiple biosensing applications that require optical functions that include bio­sensing of biological macromolecules, pharmaceuticals or other organic analytes, use quantum dots due to their high sensitivity, size-dependent emission property, cost-effectiveness and smaller size [35]. Figure3.2 could be referred for overview­ing an outline of the different constituents of different nanobiosensors.
3.3 Methodologies Involved inTransduction
Broadly there are two types of biomolecular transduction pathways: label-based transduction and label-free transduction.
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
87
Fig. 3.2 Popular technologies for developing nanobiosensors

3.3.1 Label-Based Biosensors

The native physicochemical properties of most of the biological analytes are often not enough to be detected by biosensors. Thus, labels such as uorescent, radioac­tive or enzymatic tags are required to be attached to the target analyte. The signal thus generated is in fact the proportional reading of the labels tagged with target analytes.
In case of uorescence biosensors, target analytes (e.g. antigens) with uoro­phore tag are applied on surface-immobilized detection probes (e.g. antibodies) and when they bind to the probes, the uorescence is generated [7].
Radioactivity-based detection that uses radioisotopes as labels is a technique of choice in case of applications requiring high degree of precision and sensitivity. However, because of the hazardous nature of the radio-labels, the technique is usu­ally restricted to low-throughput applications [36].
88
Biosensors in clinical sample testing and cell analysis often use enzymatic tags for their highly sensitive nature. Among several obstacles of enzymatic labelling technique, the most disrupting one is its loss of enzymatic activity over time [36].
But the system is by no means awless and comes with certain drawbacks. Apart from being quite labour-intensive and time consuming, often during the labelling, purication and multiple wash steps involved in this technique, a substantial risk of sample loss remains. Moreover, binding of different tags often may block the active binding sites for the analytes and may result in altered binding properties [7, 36].
A. Chakraborty et al.

3.3.2 Label-Free Biosensors

With astounding progress in the eld of nanotechnology and by help of modern micro-fabrication processes, label-free detection of biomolecules is now possible with extreme precision and high sensitivity. The modern nanobiosensors don’t require ligands but use the intrinsic properties of biomolecules such as molecular weight, charge, dielectric property, magnetic eld, refractive index, etc. to detect the presence of analytes. Label-free biosensing provides accurate and fast data about selectivity and afnity of bioactive molecular interactions often including the infor­mation of binding kinetics and thermodynamics [7, 36].
Depending upon the type of transducers used, label-free nanobiosensors can broadly be divided into optical and non-optical types. The typical non-optical label­free nanobiosensors again can use different detection methods that include mass­based, electrochemical and electrical, acoustic wave, magnetic detection methods, etc.
Label-free optical biosensors are mostly based on surface-plasmon-resonance (SPR). There are quantum dot-based biosensors, bio-photonic cell-based biosensors or optical resonator-based biosensors also gaining popularity among optical label­free nanobiosensor fabrication. Electrometric biosensors detect the interaction between analytes and bioreceptors in terms of change in current or voltage and can include voltametric, amperometric or impedance-measuring transducers. Mass­based mechanical detection biosensors on the other hand use nanoscale cantilevers for detecting change in resonance in free and analyte-bound sensors to determine mass of the biomolecule [7, 36, 37].

3.4 Different Nanobiosensing Techniques

Biosensors can be categorized according to the basic technologies incorporated in signal transduction and biorecognition process. The biorecognition element in a biosensor binds to the target analytes and biological signal is converted to an electri­cal signal legible to the detector. Here we shall outline some of the most popular nanobiosensing technologies.
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
89

3.4.1 Optical Sensing

Optical biosensing involves an optical transducer and bioreceptor molecule, where the optical transducer converts a biological event to electronic events in the presence of light. The analytes binding with bioreceptor induces a change in amplitude, phase, polarization, absorption, etc. picked up by the transducer. Modern optical nanobiosensors also use SPR, Raman scattering and chemiluminescence.
Absorption-based optical sensing Absorption-based optical nanobiosensors detect the change in light absorption due to the changes in the analyte concentration. The incident light absorbed by the sample is measured by an optical detector [27].
Surface plasmon resonance-based optical sensing Surface plasmon resonance (SPR) is a technique that measures surface activity. Plasmons are free electrons formed at the metal–dielectric interface. Plasmons produce an electric eld known as an evanescent wave. Polarized monochromatic light striking the prism and solu­tion interface above a certain angle known as resonance angle generates total inter­nal reection. In this situation, the photons resonate with the surface plasmons and are themselves transformed into plasmons creating a resonance wave, which can be recorded. Noble metal, e.g. gold (Au), silver (Ag), etc. lms coated over prisms can be used to create surface plasmons and are widely used for fabrication of biosen­sors. Any change on the metal surface due to binding of biomolecules, can alter the momentum changing the resonance angle for SPR resulting in a SPR shift. This shift can be recorded and interpreted in terms of biomolecular interaction, presence or activity. Noble metal nanoparticles are used in nanobiosensors instead of thin lms which are able to amplify SPR signals to many-folds providing ultrasensitive detection [7].
Fluorescence-based optical sensing In any uorescence detection mechanism, an excitation light source, uorophore molecules, lters isolating emission spectra from excitation spectra and a detector are the core components. Energy is provided by the light source and absorbed by the uorophore, producing an excited state. The most modern and commonly used uorescence detection system in nanobiosensing uses uorescence resonance energy transfer (FRET), a non-radiative quantum­mechanical technique. FRET using non-radiative mode of energy transfer among nearby uorophore/chromophores is responsible for efcient energy transfer, mak­ing them extremely sensitive to biomolecular interactions. FRET-based nanobio­sensor is a combination of a bioreceptor attached to a pair of uorophores mostly quantum dots fused with bioreceptors. Graphene-based quantum dots with gold NPs for DNA detection is a very good example for the same. Gold nanoparticles are also used as efcient universal uorescence quenchers in nanobiosensing. When the target molecule (mostly DNA) interacts with the bioreceptors immobilized with this system, the conformational change restores the uorescence which is then detected.
Chemiluminescence is a similar process to uorescence except that it utilizes energy from chemical reactions to generate excitation energy [20, 27].
90
A. Chakraborty et al.

3.4.2 Electrochemical/Electrical Sensing

The biosensors based on these technologies perform biorecognition of analytes pri­marily by recording the change in electrical events like current, voltage, impedance, etc. Electrochemical biosensors perform label-free detection of analytes with high throughput by interpreting electrochemical reactions between bioreceptors and ana­lytes on the transducer surface. Based on the operating transduction principle, the electrical sensing mechanism can be of the following types [27, 38].
Potentiometric/voltametric sensor: while applying a constant current, biochemical
reactions between bioreceptors of a biosensor and the analytes generate change
in potential which is measured by the voltametric biosensors. Voltametric nano-
biosensors use eld-effect transistors (FETs) of different kinds like ion-sensitive
FETs or graphene FETs, where biomolecular immobilization is achieved using
carbon nanomaterials like CNT or graphene and the signal is measured by accu-
mulation of biomolecules on the interface [38]. Amperometric sensor: In the presence of a constant potential, chemical interaction
between the analyte and bioreceptor immobilized on the transducer surface gen-
erates change in current. This is measured by amperometric biosensors. The
electrode of an amperometric nanobiosensor is usually made from a noble metal
nanomaterial, of carbon nanostructures covered by immobilized bioreceptors on
their surface. On application of a constant potential, the generated current by
catalytic conversion of biomolecules at the surface is measured [27]. Conductometric biosensors: they measure small change in the conductance in the
analyte solution due to their interactions with bioreceptors. Conductometric
transducers are extremely small two-electrode systems that, when a thin electro-
lyte layer is applied, measure the conductivity of the solution [38]. Impedimetric sensor: electrical impedance is the amount of resistance that a circuit
imparts on the ow of current at a certain applied potential. Any bioanalyte when
reacts with surface-immobilized bioreceptors the resistance is altered. This alter-
ation in impedance at the analyte-receptor interface is detected by the transduc-
ers to generate a reading. Single-wall CNTs, noble metal nanoparticles, etc. are
very important nanomaterials in the construction of this kind of transducers [38].

3.4.3 Magnetic Sensing

Specially designed ferrite-based magnetic nanoparticles are used for designing magnetic nanobiosensor. The magnetic nanoparticles are fabricated by incorporat­ing iron with transition metals forming an alloy having unpaired electrons in their outer orbital making their magnetic property exible to various use. Magnetic nanoparticles are great tools to separate and enrich analyte sample that are magneti­cally labelled. More recent techniques involve superconducting quantum
3 Recent Advancements in Developing Nanobiosensors for Treating Inammatory…
interference devices (SQUID) that use superparamagnetic nanoparticles to rapidly detect the analytes in most cases antigens using specic corresponding antibodies tagged with magnetic nanoparticles [20, 24].
91

3.4.4 Mass-Based Sensing

Mass-based mechanical detection of analytes is achieved by the use of nanoscaled cantilever sensors. Nanocantilevers are exible beams, xed at one side and are usu­ally made up of silicon or quartz. Biorecognition molecules are immobilized on the cantilevers that bind target molecules if present in the analysis media. This added mass of the analytes alters the conformation or resonating properties of the nano­cantilevers. Being in nanoscale increases the sensitivity of the sensor as smallest addition of mass will affect those properties signicantly. Also, one of the inherent properties of any nanomaterial being its increased aspect ratio provides more sur­face for biomolecules to attach on the nanocantilevers [26].
Depending on the mode of excitation, nanocantilever biosensors can be deection- based or static nanocantilever sensor and resonance-based or dynamic nanocantilever sensor.
In static cantilevers, binding of analytes deects the beam from its original posi­tion in proportion to the mass-binding. In dynamic sensors, the captured analyte will add mass to the cantilever to affect its resonating frequency. In both cases, nanocantilevers that are not bound with analytes are used as controls to compare the shift in the conformation or resonance [7, 26].
3.5 Tribology ofNanoparticles intheContext
ofDeveloping Nanobiosensors
Tribology, the study of interacting surfaces in relative motion, plays a pivotal role in optimizing the performance, reliability and durability of nanobiosensors. Tribology focuses on the friction, wear and lubrication between interacting surfaces [39]. Friction, wear and lubrication between materials in contact are of utmost impor­tance in scientic applications [40]. Tribological considerations are critical in nano­biosensors as they directly inuence the functionality, sensitivity and lifespan of these sensors. Nanomaterials, such as nanoparticles, nanowires and nanostructured lms, are commonly employed in the fabrication of nanobiosensors due to their unique physical, chemical and biological properties. These materials exhibit distinct tribological behaviours that signicantly impact the performance of nanobiosensors in disease detection applications. Highly sensitive nanobiosensors are manufactured by incorporating nanomaterials designed with nanoelectromechanical systems (NEMS) that give complex tribological properties. With the implementation of